Role of surgery in ovarian cancer: An updateVERGOTE, I.Acta chirurgica Belgica. 2004, Num 3, pp 246-256, issn 0001-5458, 11 p.Article

Fulvestrant versus anastrozole as second-line treatment of advanced breast cancer in postmenopausal womenVERGOTE, I.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 6, pp S57-S58, issn 1359-6349Conference Paper

DYSGERMINOMA OF THE OVARY IN ASSOCIATION WITH XY GONADAL DYSGENESISVERGOTE I; DIELEMAN V; BECQUART D et al.1983; EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY; ISSN 0301-2115; NLD; DA. 1983; VOL. 14; NO 6; PP. 385-391; BIBL. 20 REF.Article

Fulvestrant, a new treatment option for advanced breast cancer : tolerability versus existing agentsVERGOTE, I; ABRAM, P.Annals of oncology. 2006, Vol 17, Num 2, pp 200-204, issn 0923-7534, 5 p.Article

Quality of life in patients receiving treatment for gynecologic malignancies: Special considerations for patient careWENZEL, L; VERGOTE, I; CELLA, D et al.International journal of gynecology & obstetrics. Supplement. 2003, Vol 83, Num 1, pp 211-229, issn 0924-8447, 19 p.Article

Endocrine Treatment and Prevention of Breast and Gynaecological Cancers. 3rd Biennial International Meeting of the Flemish Gynaecological Oncology GroupVERGOTE, I; NEVEN, P.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 6, issn 1359-6349, 99 p.Conference Proceedings

An update on non-gynaecological effects of SERM's and aromatase inhibitorsNETELENBOS, C.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 6, pp S63-S64, issn 1359-6349Conference Paper

Tamoxifen for primary breast cancer prevention in BRCA heterozygotesROBSON, M.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 6, pp S18-S19, issn 1359-6349Conference Paper

Detection of the oestrogen receptor (ER) : immunohistochemical versus cytosol measurementsLEAKE, R.European journal of cancer. Supplement (1990). 2000, Vol 36, Num 4, pp S18-S19, issn 1359-6349Conference Paper

Oestrogen receptor determination in breast and gynaecological tissue. What is the best approach to reproducible measurement?LEAKE, R.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 6, pp S33-S34, issn 1359-6349Conference Paper

Arzoxifene in breast cancerCHAN, S.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 6, pp S55-S56, issn 1359-6349Conference Paper

Faslodex (ICI 182780) : an oestrogen receptor downregulatorHOWELL, A.European journal of cancer. Supplement (1990). 2000, Vol 36, Num 4, pp S87-S88, issn 1359-6349Conference Paper

Soyfoods and soybean phyto-oestrogens (isoflavones) as possible alternatives to hormone replacement therapy (HRT)MESSINA, M.European journal of cancer. Supplement (1990). 2000, Vol 36, Num 4, pp S71-S72, issn 1359-6349Conference Paper

Taximoxifen and the uterus: potential uterine risks of anti-oestrogensVERGOTE, I; NEVEN, P.European journal of cancer. Supplement (1990). 1998, Vol 34, Num 4, issn 1359-6349, 71 p.Conference Proceedings

Endocrine treatment and prevention of breast and gynaecological cancers: proceedings and extented abstractsNEVEN, P; VERGOTE, I.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 9, issn 1359-6349, 117 p.Conference Proceedings

The origin of postmenopausal oestrogensNEVEN, P.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 6, pp S29-S30, issn 1359-6349Conference Paper

The feasibility of open laparoscopy in gynecologic-oncologic patientsDECLOEDT, J; BERTELOOT, P; VERGOTE, I et al.Gynecologic oncology (Print). 1997, Vol 66, Num 1, pp 138-140, issn 0090-8258Article

Placental alkaline phosphatase as a tumor marker in ovarian cancerVERGOTE, I; ONSRUD, M; NUSTAD, K et al.Obstetrics and gynecology (New York. 1953). 1987, Vol 69, Num 2, pp 228-232, issn 0029-7844Article

A review of the efficacy of anastrozole in postmenopausal women with advanced breast cancer with visceral metastasesHOWELL, A; ROBERTSON, J. F. R; VERGOTE, I et al.Breast cancer research and treatment. 2003, Vol 82, Num 3, pp 215-222, issn 0167-6806, 8 p.Article

New SERMs in developmentNEVEN, P.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 6, pp S26-S27, issn 1359-6349Conference Paper

Selective oestrogen receptor downregulatorHOWELL, Anthony.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 6, pp S61-6S2, issn 1359-6349Conference Paper

An overview of the use of non-steroidal aromatase inhibitors in the treatment of breast cancerBUZDAR, A.European journal of cancer. Supplement (1990). 2000, Vol 36, Num 4, pp S82-S84, issn 1359-6349Conference Paper

Role of LHRH agonists in premenopausal women with oestrogen receptor-positive breast cancer: the ZEBRA experienceJONAT, W.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 6, pp S39-S40, issn 1359-6349Conference Paper

Oestrogen and female cancers : the past 100 yearsNEVEN, P.European journal of cancer. Supplement (1990). 2000, Vol 36, Num 4, pp S13-S14, issn 1359-6349Conference Paper

Gastrostomy using a Gastrofix as an alternative for nasogastric tubes in ovarian cancer surgeryAMANT, F; BERTELOOT, P; VERGOTE, I et al.Gynecologic oncology (Print). 1998, Vol 71, Num 3, pp 348-351, issn 0090-8258Article